Literature DB >> 21538285

Genetic modifiers of liver injury in hereditary liver disease.

Aftab Ala1, Michael Schilsky.   

Abstract

The genetic background of patients with liver diseases modulates hepatic injury, with some individuals being predisposed to better defenses and regenerative capacity. In this review, we focus our description of this phenomenon on inherited disorders affecting the liver, with a particular emphasis on Wilson disease (WD), genetic hemochromatosis, and α-1 anti-trypsin disease (A1-AT). Wide variations in the clinical phenotype of WD may in part be related to the mutations of the ATP7B genotype, though modifier genes and environmental factors also likely play an important role. There is also a significant variability in the expression of iron overload in patients with genetic hemochromatosis that are homozygous for the C282Y mutation. Homozygosity for the A1-ATZ mutation is generally required for the development of liver disease in A1-AT although there is increasing evidence for modifier effects from a heterozygous genotype in other liver diseases.
© 2011 Thieme Medical Publishers, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21538285     DOI: 10.1055/s-0031-1276648

Source DB:  PubMed          Journal:  Semin Liver Dis        ISSN: 0272-8087            Impact factor:   6.115


  7 in total

Review 1.  A Next Generation Multiscale View of Inborn Errors of Metabolism.

Authors:  Carmen A Argmann; Sander M Houten; Jun Zhu; Eric E Schadt
Journal:  Cell Metab       Date:  2015-12-17       Impact factor: 27.287

Review 2.  Wilson disease.

Authors:  Anna Członkowska; Tomasz Litwin; Petr Dusek; Peter Ferenci; Svetlana Lutsenko; Valentina Medici; Janusz K Rybakowski; Karl Heinz Weiss; Michael L Schilsky
Journal:  Nat Rev Dis Primers       Date:  2018-09-06       Impact factor: 52.329

3.  Wilson Disease: Epigenetic effects of choline supplementation on phenotype and clinical course in a mouse model.

Authors:  Valentina Medici; Dorothy A Kieffer; Noreene M Shibata; Harpreet Chima; Kyoungmi Kim; Angela Canovas; Juan F Medrano; Alma D Islas-Trejo; Kusum K Kharbanda; Kristin Olson; Ruijun J Su; Mohammad S Islam; Raisa Syed; Carl L Keen; Amy Y Miller; John C Rutledge; Charles H Halsted; Janine M LaSalle
Journal:  Epigenetics       Date:  2016-09-09       Impact factor: 4.528

4.  Wilson's disease in an adult asymptomatic patient: a potential role for modifying factors of copper metabolism.

Authors:  Georgios Loudianos; Simona Incollu; Eva Mameli; Maria B Lepori
Journal:  Ann Gastroenterol       Date:  2016 Jan-Mar

5.  Liver biopsy derived induced pluripotent stem cells provide unlimited supply for the generation of hepatocyte-like cells.

Authors:  Diego Calabrese; Guglielmo Roma; Sebastian Bergling; Walter Carbone; Valentina Mele; Sandro Nuciforo; Isabel Fofana; Benedetta Campana; Dagmara Szkolnicka; David C Hay; Jan Tchorz; Tewis Bouwmeester; Stefan Wieland; Markus H Heim
Journal:  PLoS One       Date:  2019-08-29       Impact factor: 3.240

Review 6.  An update on laboratory diagnosis of liver inherited diseases.

Authors:  Federica Zarrilli; Ausilia Elce; Manuela Scorza; Sonia Giordano; Felice Amato; Giuseppe Castaldo
Journal:  Biomed Res Int       Date:  2013-10-08       Impact factor: 3.411

7.  Association of Variants in the CP, ATOX1 and COMMD1 Genes with Wilson Disease Symptoms in Latvia.

Authors:  A Zarina; I Tolmane; Z Krumina; A I Tutane; L Gailite
Journal:  Balkan J Med Genet       Date:  2019-12-21       Impact factor: 0.519

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.